{"transactions":[{"id":927524,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":7.8,"value":780000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options will vest and be exercisable on the first date on which the average closing price (rounded to the nearest penny) of the Company's listed stock for the then previous forty five (45) calendar days is equal to or greater than the $24.00 Strike Price."}],"balance_after":774163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927523,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":7.8,"value":780000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options will vest and be exercisable on the first date on which the average closing price (rounded to the nearest penny) of the Company's listed stock for the then previous forty five (45) calendar days is equal to or greater than the $16.00 Strike Price."}],"balance_after":674163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927522,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":7.8,"value":1170000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest and be exercisable if (i) the Company achieves EBITDA of $35 million over any consecutive four quarter period  (based on the Company's fiscal year) or (ii) when $30 million of the Company's data revenue is recognized over any consecutive four quarter period (based on the Company's fiscal year)."}],"balance_after":574163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927521,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":7.8,"value":487500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest and be exercisable when $15 million of the Company's data revenue is recognized over any consecutive four quarter period (based on the Company's fiscal year)."}],"balance_after":424163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927520,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":7.8,"value":487500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest and be exercisable if the Company achieves EBITDA of $25 million over any consecutive four quarter period (based on the Company's fiscal year)."}],"balance_after":361663,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927519,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T20:55:35.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":7.8,"value":1755000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable as follows: 25% will vest on the one-year anniversary of the grant date on July 16, 2026; the balance will vest ratably at a rate of 1/36th each month thereafter."}],"balance_after":299163,"derivative":{"exercise_price":7.8,"expiration_date":"2035-07-16","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001628280-26-004381","document":"wk-form4_1769806532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004381/wk-form4_1769806532.xml","form_type":"4"}},{"id":927517,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T17:15:54.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":23030,"price":4.64,"value":106859.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":74163,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":23030},"source":{"system":"sec-edgar","filing":"0001628280-26-004342","document":"wk-form4_1769793351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004342/wk-form4_1769793351.xml","form_type":"4"}},{"id":927516,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T17:15:54.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":19070,"price":5.51,"value":105075.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 3, 2023,  February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":51133,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":19070},"source":{"system":"sec-edgar","filing":"0001628280-26-004342","document":"wk-form4_1769793351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004342/wk-form4_1769793351.xml","form_type":"4"}},{"id":927515,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T17:15:54.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":14130,"price":7,"value":98910.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2022, February 1, 2023, May 1, 2023 and August 1, 2023, respectively."}],"balance_after":32063,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":14130},"source":{"system":"sec-edgar","filing":"0001628280-26-004342","document":"wk-form4_1769793351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004342/wk-form4_1769793351.xml","form_type":"4"}},{"id":927514,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":68440,"kind":"person","name":"Brainin Robert Lawrence","position":1,"cik":"0002088015","reported_name":"Brainin Robert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-01-30T17:15:54.000Z","date":"2021-11-05","kind":"grant","planned":false,"acquired":true,"shares":9901,"price":10.1,"value":100000.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5, 2022, respectively."}],"balance_after":17933,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":9901},"source":{"system":"sec-edgar","filing":"0001628280-26-004342","document":"wk-form4_1769793351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828026004342/wk-form4_1769793351.xml","form_type":"4"}}]}